Welcome to Market Catalyst. I'm Julie Hyman. We are 30 minutes into the US trading day.Let's get to the three market catalyst we're watching this hour. First up, Oracle shares surging on its strong outlook. More on those results ahead.Plus, wholesale inflation unexpectedly declines. What does that mean for the Fed. and President Trump floats new tariffs on China and India.We'll bring you the latest on trade and much more on Market Catalysts. But first, let's get a check of the markets here because we are se ...

Mexico will raise its tariffs on automobiles from China and other Asian countries to 50%, from a prior level of 20%, Economy Minister Marcelo Ebrard said on Wednesday. ...

Luda Technology Group has entered a strategic partnership with prominent Chinese shipbuilders to foster research and manufacturing of speciality-material flanges and pipe fittings for ammonia-fuelled vessels. This initiative represents an advancement in the Chinese shipbuilding sector's pursuit of supply chain independence and transformation of essential components. The companies involved in the partnership include China State Shipbuilding Corporation (CSSC), Haiting (Nantong) Shipbuilding Company, and C ...

Key Takeaways Mission Produce's Q3 revenues rose 10% YoY to $357.7M with an adjusted net income of $18.2M.International Farming segment sales surged 79% YoY, with EBITDA up 163%.Low debt, controlled capex and scalable global supply position Mission Produce for continued growth.Mission Produce, Inc.’s (AVO) third-quarter fiscal 2025 results highlight the growing influence of its International Farming operations, signaling that the company’s long-term investments in global sourcing and vertical integration ar ...

Key Takeaways Snowflake stock rose 17.6% in a month, beating the tech sector's 2.9% and internet software's 0.8%. Growth is fueled by expanding AI partnerships, portfolio launches, and strong customer adoption. Snowflake guides Q3 revenue of $1.125B-$1.13B, projecting 25%-26% year-over-year product revenue growth. Snowflake (SNOW) shares have soared 17.6% in one month, outperforming the Zacks Computer and Technology sector’s growth of 2.9% and the Zacks Internet Software industry’s increase of 0.8%. The out ...

Key Takeaways Rigetti placed its 9-qubit Novera system at Montana State's QCORE facility.The collaboration aims to accelerate research and foster quantum education.RGTI shares are up 8.1% year-to-date, trailing the industry's 21% gain.Rigetti Computing’s (RGTI) has recently strengthened its academic presence through a new collaboration with Montana State University’s (MSU) QCORE facility. The university is now the first academic institution to host a Rigetti quantum computer on premises, featuring the compa ...

Key Takeaways MP Materials stock has soared 146.3% in three months, outpacing industry and market gains.Apple supply deal and DoD partnership boosted MP's rally and growth prospects.Q2 output surged 119% for neodymium, with revenues up 84% year over year.MP Materials (MP) shares have soared 146.3% in the past three months, far outpacing the industry’s 0.5% growth, the Zacks Basic Materials sector’s 6.5% rise and the S&P 500’s gain of 9.4%.The stock’s rally has been driven by major developments during this p ...

If you want full access to all our reports, data and investing ideas, join The Aerospace Forum , the #1 aerospace, defense and airline investment research service on Seeking Alpha, with access to evoX Data Analytics, our in-house developed data analytics platform.Nebius Group N.V. (NASDAQ: NBIS ) has surged almost 50% following the announcement of a $17.4 billion deal with Microsoft ( MSFT ). Since my last report , the stock price has now increased 45%. TheDhierin runs the investing group The Aerospace Foru ...

For contrarian investors, sometimes it's useful to go through 52-week lows on the stock market looking for bargains. It's not always easy; there are some very bad companies on there, crumbling relics and companies stuck in the reverse-split spiral. Sometimes, though, you findI’m Jason Ditz and I have 20 years of experience in foreign policy research. My work has appeared in Forbes, Toronto Star, Minneapolis Star-Tribune, Providence Journal, Washington Times and the Detroit Free Press, as well as American Co ...

PresentationRay, I thought I'd turn it over to you for some opening remarks before we go into questions. But thanks so much again.Great. Thanks for joining us, everyone. I'm Terence Flynn, the U.S. biopharma analyst here at Morgan Stanley. I'm very pleased to be hosting Structure Therapeutics. Joining us today from the company, we have the company's CEO, Ray Stevens. Ray, thanks so much for being here. Just before we get started, for important disclosures, please see the Morgan Stanley research disclosure w ...